Tuesday, May 07 2024
09:37 AM – 10:00 AM ET - Ballroom 1
LNP development and screening
James Dahlman - PhD
Georgia Tech
Disclosures: J. Dahlman: 1; Commercial Interest i.e. Company X; Nava Therapeutics. 1; What was received? i.e. Honorarium; Consulting fee. 1; For what role? i.e. Speaker; Advisor. 2; Commercial Interest i.e. Company X; GV. 2; What was received? i.e. Honorarium; Consulting fee. 2; For what role? i.e. Speaker; Advisor. 3; Commercial Interest i.e. Company X; Edge Animal Health. 3; What was received? i.e. Honorarium; Consulting fee. 3; For what role? i.e. Speaker; Advisor.